NF-κB (p65) was weakly positively expressed in the NEC model group following rhTFF3 treatment, and the tissue homogenate IL-1β content was decreased, suggesting that rhTFF3 inhibits NF-κB metabolic synthesizing products by inhibiting its expression. This evidence concerns the gene IL1B and necrotizing enterocolitis.